The published rodent literature has not reported overt toxicity at the studied amounts, but the available data are not equivalent to a regulated Phase 1/2 safety database
Be patient - most people see initial results after 4-6 weeks of regular use
Our findings make sense from a theoretical standpoint, since GLP-1 medications do have an anti-inflammatory mechanism, but we cant guarantee the association with uveitis. More research with different methodologies, such as retrospective chart reviews and prospective trials, is needed to confirm the findings and inform clinical practice
Since 2005, multiple GLP-1R agonists resembling exendin-4 have been developed ( Figure 2 ), with fatty-acid modifications to increase half-life and facilitate less frequent dosing regimes
TRICARE eligibility, Military Benefit Association FDA approves new drug treatment for chronic weight management, first since 2014 U.S
With the same dosage and price, it can maintain up to 20 times longer-lasting effects (similar to the difference between an IV drip and a single injection)